Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sigilon Therapeutics, Inc. - Common Stock (NQ: SGTX )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 10, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sigilon Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Why These 3 Large Caps Are Bucking the August Slump
The three largest S&P 500 outperformers of August are tacking on gains in a weak market, making them intriguing momentum plays to watch for the rest of 2023. 
Via MarketBeat
Topics Economy Stocks
Exposures Fossil Fuels Interest Rates US Equities
Over $25M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed mostly higher on Monday, there were a few notable insider trades. 
Via Benzinga
Eli Lilly To Report Q2 Earnings: What's In The Cards?
Eli Lilly & Company will report second-quarter 2023 results on Aug. 8, before the market opens. 
Via Talk Markets
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: American Equity Investment Life Holding Company (NYSE – AEL), Amedisys, Inc. (Nasdaq – AMED), Sigilon Therapeutics, Inc (Nasdaq – SGTX)
From Brodsky & Smith LLC
Via GlobeNewswire
Sigilon Therapeutics Inc. (NASDAQ: SGTX) Near the Top of Equities by Percentage Gain on 6/29
Via Investor Brand Network
Health Care Company Eli Lilly Announces Acquisition of Sigilon Therapeutics
Via Benzinga
SIGILON THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sigilon Therapeutics, Inc. - SGTX
From Kahn Swick & Foti, LLC
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: American Equity Investment Life Holding Company (NYSE – AEL), Amedisys, Inc. (Nasdaq – AMED), Sigilon Therapeutics, Inc (Nasdaq – SGTX)
From Brodsky & Smith LLC
Via GlobeNewswire
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Sigilon Therapeutics, Inc (Nasdaq – SGTX)
From Brodsky & Smith LLC
Via GlobeNewswire
Sigilon Therapeutics's Return On Capital Employed Overview
Via Benzinga
SIGILON THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sigilon Therapeutics, Inc. - SGTX
From Kahn Swick & Foti, LLC
Via Business Wire
Stock Market Rally Roars Back Toward Highs; Carnival, Delta, Micron, Nvidia In Focus: Weekly Review
Major indexes rebounded strongly and many stocks flashed buy signals. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2023
Via Benzinga
Tesla, Nike, Sigilon Therapeutics Among Top Trending Stocks Today
Via Benzinga
Nasdaq Moves Lower; Acuity Brands Earnings Top Estimates
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 200 points on Thursday. The Dow traded up 0.68% to 34,081.83 while the NASDAQ fell 0.23% to 13,560.57. The S&P... 
Via Benzinga
Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares climbed 523.8% to $24.25 after Eli Lilly agreed to acquire the company for $14.92/share in cash. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Crude Oil Edges Higher; McCormick Posts Upbeat Earnings
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Thursday. The Dow traded up 0.64% to 34,069.87 while the NASDAQ rose 0.13% to 13,609.09. The S&P... 
Via Benzinga
Dow Rises Over 100 Points; US GDP Grows 2% In Q1
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.37% to 33,977.04 while the NASDAQ rose... 
Via Benzinga
Sigilon Therapeutics Scores Eli Lilly Buyout And Skyrockets More Than 500%
Eli Lilly is getting deeper into type 1 diabetes treatment with this buyout. 
Via Investor's Business Daily
Sigilon Therapeutics Shares Are Shooting Higher Today - What's Going On
Sigilon Therapeutics Inc (NASDAQ: SGTX) shares are skyrocketing after Eli Lilly And Co (NYSE: LLY) agreed to acquire the company for a purchase price of $14.92 per share in cash (an aggregate of  
Via Benzinga
Why Is Cormedix (CRMD) Stock Down 23% Today?
Cormedix (CRMD) stock is falling hard on Thursday with heavy trading after the company priced a public offering of its shares. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Is BioXcel Therapeutics (BTAI) Stock Down 57% Today?
BioXcel Therapeutics (BTAI) stock is taking a beating on Thursday after the company released its latest clinical trial data. 
Via InvestorPlace
SGTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Sigilon Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Why Is Eco Wave Power Global (WAVE) Stock Up 58% Today?
Eco Wave Power Global (WAVE) stock is on the rise Thursday with heavy trading despite a lack of news concerning the wave energy company. 
Via InvestorPlace
Why Is Sigilon Therapeutics (SGTX) Stock Up 691% Today?
Sigilon Therapeutics (SGTX) stock is rocketing higher on Thursday morning after Eli Lilly (LLY) agrees to acquire the company. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting Thursday with a detailed look at all of the biggest pre-market stock movers worth keeping an eye on today! 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share. 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.